Quarterly report pursuant to Section 13 or 15(d)

Preliminary Purchase Price - Summary of Shares Issuance of Merger Agreement (Details)

v3.21.1
Preliminary Purchase Price - Summary of Shares Issuance of Merger Agreement (Details) - Pro Forma [Member] - shares
 4 Months Ended
Apr. 16, 2021
Apr. 16, 2021
Mar. 03, 2021
Shares of Company common stock outstanding as of April 16, 2021     8,326,730
Divided by the assumed percentage of Company ownership of the combined company   22.95%  
Estimated adjusted total shares of common stock of the combined company   42,493,817  
Multiplied by the assumed percentage of pre-Merger MyMD Florida ownership of the combined company   77.05%  
Estimated shares of Company's common stock issued to pre-Merger MyMD Florida upon closing of the Merger   32,741,622  
Subsequent Event [Member]      
Shares of Company common stock outstanding as of April 16, 2021 8,326,730 8,326,730  
Shares of Company common stock subject to Series D Convertible Preferred stock 36,496 36,496  
Shares of Company common stock subject to outstanding restricted stock units 402,483    
Shares of Company common stock subject to outstanding pre-funded warrants [1] 986,486 986,486  
Adjusted outstanding shares of Company common stock 9,752,195    
Divided by the assumed percentage of Company ownership of the combined company 22.95%    
Estimated adjusted total shares of common stock of the combined company 42,493,817    
Multiplied by the assumed percentage of pre-Merger MyMD Florida ownership of the combined company 77.05%    
Estimated shares of Company's common stock issued to pre-Merger MyMD Florida upon closing of the Merger [2] 32,741,622    
[1] 986,486 shares of Company common stock underlying outstanding the Company's pre-funded warrants are included in the calculation of the estimated total number of shares to be issued upon the completion of the Merger. An additional 5,463,032 shares issuable upon exercise of the outstanding the Company's warrants with a strike price in excess of $3.44 were excluded per the Merger Agreement.
[2] The common stock issued to pre-Merger MyMD Florida upon closing includes 4,188,315 shares allocated to fully vested stock options of pre-Merger MyMD Florida assumed by the Company upon closing, which will expire two years from the effective date of the Merger. Pursuant to the terms of the Merger Agreement, shares have been allocated to pre-Merger MyMD Florida's outstanding stock options, however, there is no requirement for these options to be exercised as of the effective date of the Merger.